Randomised clinical trial: a novel rabeprazole extended release 50 mg formulation vs. esomeprazole 40 mg in healing of moderate-to-severe erosive oesophagitis - the results of two double-blind studies-Reference-Cited by-同舟云学术

Randomised clinical trial: a novel rabeprazole extended release 50 mg formulation vs. esomeprazole 40 mg in healing of moderate-to-severe erosive oesophagitis - the results of two double-blind studies

Published:2010-11-30 Issue:2 Volume:33 Page:203-212
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:

Author:

Laine L.,Katz P. O.,Johnson D. A.,Ibegbu I.,Goldstein M. J.,Chou C.,Rossiter G.,Lu Y.

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2036.2010.04516.x/fullpdf

Reference33 articles.

1. Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trial. The Esomeprazole Study Investigators;Kahrilas;Aliment Pharmacol Ther,2000

2. Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial;Richter;Am J Gastroenterol,2001

3. Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis;Castell;Am J Gastroenterol,2002

4. A randomized comparative study of esomeprazole 40 mg versus pantoprazole 40 mg for healing erosive oesophagitis: the EXPO study;Labenz;Aliment Pharmacol Ther,2005

5. Nexium (esomeprazole magnesium) delayed release capsules approval package, NDA Application No.: 21-153 & 21-154 http://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/21154_Nexium.cfm

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Los Angeles Grades of Erosive Esophagitis Scored by Local Investigators vs Central Adjudicators in a Clinical Trial;Clinical Gastroenterology and Hepatology;2024-05

2. Comparative Efficacy of P-CAB vs Proton Pump Inhibitors for Grade C/D Esophagitis: A Systematic Review and Network Meta-analysis;American Journal of Gastroenterology;2024-03-22

3. The efficacy and safety of fexuprazan in treating erosive esophagitis: a phase III, randomized, double‐blind, multicenter study;Journal of Gastroenterology and Hepatology;2024-01-22

4. Medical Therapy for Gastroesophageal Reflux Disease;Gastroesophageal Reflux Disease;2023

5. Induction and maintenance of healing in erosive esophagitis in the United States;Expert Review of Gastroenterology & Hepatology;2022-10-03